KAPANYSE United States
Market cap
$8.265 M
$0.39 -1.03%
Close of 7 Aug 2026
Revenue
—
Not reported
Earnings
-$5.45M
Loss-making
Shares outstanding
21,411,198
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Kairos Pharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.